Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Werewolf Therapeutics, Inc. (HOWL)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
   10-K10-K10-KS-1/A
Revenues   [+]1.90.10.06.3
            Revenue growth  1734.6% -100.0% 
Cost of goods sold  -14.50.10.012.7
Gross profit  16.40.00.0-6.3
            Gross margin  859.6%0.0% -100.0%
Selling, general and administrative   [+]18.714.85.83.6
Research and development  53.835.316.6 
EBITDA   [+]-55.0-49.9-22.3-9.9
            EBITDA margin  -2880.1%-47952.9% -156.3%
Depreciation and amortization  1.10.20.20.0
EBIT   [+]-56.1-50.1-22.4-9.9
            EBIT margin  -2937.9%-48160.6% -156.7%
Interest expense, net   [+]  -0.10.4
Other income (expense), net  2.20.17.30.1
Pre-tax income  -53.8-50.0-15.0-10.2
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income  -53.8-201.9-28.2-18.2
            Net margin  -2820.2%-194158.7% -287.5%
   
Basic EPS   [+]($1.86)($10.94)($28.08)($28.49)
Diluted EPS   [+]($1.86)($10.94)($28.08)($28.49)
   
Shares outstanding (basic)   [+]28.918.51.00.6
Shares outstanding (diluted)   [+]28.918.51.00.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy